Emerging roles of E2Fs in cancer: an exit from cell cycle control

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Nature Reviews. Cancer

• Publication date

  2009-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/nrc2696PMID 19851314PMCID PMC3616489
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• E2f1, E2f2, and E2f3 Control E2F Target Expression and Cellular Proliferation via a p53-Dependent Negative Feedback Loop

  2012cited by this paper
• E2Fs mediate a fundamental cell‐cycle deregulation in high‐grade serous ovarian carcinomas

  2009cited by this paper
• Cell cycle, CDKs and cancer: a changing paradigm

  2009cited by this paper
• Division and apoptosis of E2f-deficient retinal progenitors

  2009cited by this paper
• E2F7 can regulate proliferation, differentiation, and apoptotic responses in human keratinocytes: implications for cutaneous squamous cell carcinoma formation.

  2009cited by this paper
• Atypical E2Fs: new players in the E2F transcription factor family.

  2009cited by this paper
• E2F1-3 Switch from Activators in Progenitor Cells to Repressors in Differentiating Cells

  2009cited by this paper
• Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome

  2009cited by this paper
• Context-Dependent Requirement for dE2F during Oncogenic Proliferation

  2008cited by this paper
• Inactivation of the Rb pathway and overexpression of both isoforms of E2F3 are obligate events in bladder tumours with 6p22 amplification

  2008cited by this paper
• The quest for the 1p36 tumor suppressor.

  2008cited by this paper
• Switching cyclin D-Cdk4 kinase activity on and off

  2008cited by this paper
• Mouse development with a single E2F activator

  2008cited by this paper
• DNA‐damage response control of E2F7 and E2F8

  2008cited by this paper
• Characterization of amplicons in neuroblastoma: High‐resolution mapping using DNA microarrays, relationship with outcome, and identification of overexpressed genes

  2008cited by this paper
• Molecular targeted therapies in hepatocellular carcinoma

  2008cited by this paper
• E2f3a and E2f3b Contribute to the Control of Cell Proliferation and Mouse Development

  2008cited by this paper
• E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity

  2008cited by this paper
• Inhibition of pituitary tumors in Rb mutant chimeras through E2f4-loss reveals a key suppressive role for the pRB/E2F pathway in urothelium and ganglionic carcinogenesis

  2008cited by this paper
• Synergistic function of E2F7 and E2F8 is essential for cell survival and embryonic development.

  2008cited by this paper
• Overexpression of E2F5/p130, but not E2F5 alone, can inhibit E2F-induced cell cycle entry in transgenic mice

  2008cited by this paper
• E2F2 represses cell cycle regulators to maintain quiescence

  2008cited by this paper
• CDK8 is a colorectal cancer oncogene that regulates β-catenin activity

  2008cited by this paper
• Integrated genomic and transcriptional profiling identifies chromosomal loci with altered gene expression in cervical cancer

  2008cited by this paper
• Atypical E2F activity restrains APC/CCCS52A2 function obligatory for endocycle onset

  2008cited by this paper
• Cellular mechanisms of tumour suppression by the retinoblastoma gene

  2008cited by this paper
• Impact of E2F-1 Expression on Clinical Outcome of Gastric Adenocarcinoma Patients with Adjuvant Chemoradiation Therapy

  2008cited by this paper
• A role for Myc in facilitating transcription activation by E2F1

  2008cited by this paper
• Genetic substitution of Cdk1 by Cdk2 leads to embryonic lethality and loss of meiotic function of Cdk2

  2008cited by this paper
• Specific tumor suppressor function for E2F2 in Myc-induced T cell lymphomagenesis

  2007cited by this paper
• CpG Island Methylation in a Mouse Model of Lymphoma Is Driven by the Genetic Configuration of Tumor Cells

  2007cited by this paper
• Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors.

  2007cited by this paper
• Strength in numbers: preventing rereplication via multiple mechanisms in eukaryotic cells.

  2007cited by this paper
• Specific In Vivo Roles for E2Fs in Differentiation and Development

  2007cited by this paper
• Polycomb complexes regulate cellular senescence by repression of ARF in cooperation with E2F3

  2007cited by this paper
• Rb is critical in a mammalian tissue stem cell population.

  2007cited by this paper
• Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges.

  2007cited by this paper
• E2F-associated chromatin modifiers and cell cycle control.

  2007cited by this paper
• Intestinal Hyperplasia Induced by Simian Virus 40 Large Tumor Antigen Requires E2F2

  2007cited by this paper
• dE2F2-Independent Rescue of Proliferation in Cells Lacking an Activator dE2F1

  2007cited by this paper
• Array CGH identifies distinct DNA copy number profiles of oncogenes and tumor suppressor genes in chromosomal- and microsatellite-unstable sporadic colorectal carcinomas

  2007cited by this paper
• Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors.

  2007cited by this paper
• Selective Requirements for E2f3 in the Development and Tumorigenicity of Rb-Deficient Chimeric Tissues

  2007cited by this paper
• Repression of RAD51 gene expression by E2F4/p130 complexes in hypoxia

  2007cited by this paper
• E2F1 Overexpression Correlates with Thymidylate Synthase and Survivin Gene Expressions and Tumor Proliferation in Non–Small-Cell Lung Cancer

  2007cited by this paper
• E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases.

  2007cited by this paper
• Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation.

  2007cited by this paper
• Mechanisms controlling cell cycle exit upon terminal differentiation.

  2007cited by this paper
• Life and death decisions by the E2F transcription factors.

  2007cited by this paper
• E2f1, E2f2, and E2f3 Control E2F Target Expression and Cellular Proliferation via a p53-Dependent Negative Feedback Loop

  2007cited by this paper
• Cdk1 is sufficient to drive the mammalian cell cycle

  2007cited by this paper
• A comprehensive ChIP-chip analysis of E2F1, E2F4, and E2F6 in normal and tumor cells reveals interchangeable roles of E2F family members.

  2007cited by this paper
• Clinical Relevance of E2F Family Members in Ovarian Cancer—An Evaluation in a Training Set of 77 Patients

  2007cited by this paper
• Nuclear overexpression of the E2F3 transcription factor in human lung cancer.

  2006cited by this paper
• Microarray‐based CGH of sporadic and syndrome‐related pheochromocytomas using a 0.1–0.2 Mb bacterial artificial chromosome array spanning chromosome arm 1p

  2006cited by this paper
• Molecular mechanisms of pancreatic carcinogenesis

  2006cited by this paper
• E2F3a Stimulates Proliferation, p53-Independent Apoptosis and Carcinogenesis in a Transgenic Mouse Model

  2006cited by this paper
• Basal repression of BRCA1 by multiple E2Fs and pocket proteins at adjacent E2F sites

  2006cited by this paper
• A computational genomics approach to identify cis-regulatory modules from chromatin immunoprecipitation microarray data--a case study using E2F1.

  2006cited by this paper
• Requirement for CDK4 kinase function in breast cancer.

  2006cited by this paper
• Expression of the E2F Family of Transcription Factors and Its Clinical Relevance in Ovarian Cancer

  2006cited by this paper
• Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome.

  2006cited by this paper
• E2f4 regulates fetal erythropoiesis through the promotion of cellular proliferation.

  2006cited by this paper
• Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 Is Essential for G1/S Progression and Cellular Transformation*

  2006cited by this paper
• Expression analysis of 6p22 genomic gain in retinoblastoma

  2006cited by this paper
• Increased gene copy numbers at chromosome 20q are frequent in both squamous cell carcinomas and adenocarcinomas of the cervix

  2006cited by this paper
• Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis.

  2006cited by this paper
• Cell cycle regulator E2F1 modulates angiogenesis via p53-dependent transcriptional control of VEGF.

  2006cited by this paper
• Retinoblastoma regulatory pathway in lung cancer.

  2006cited by this paper
• Distinct Capacities of Individual E2Fs to Induce Cell Cycle Re-Entry in Postmitotic Lens Fiber Cells of Transgenic Mice

  2005cited by this paper
• Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.

  2005cited by this paper
• The E2F transcriptional network: old acquaintances with new faces

  2005cited by this paper
• ERBB receptors and cancer: the complexity of targeted inhibitors

  2005cited by this paper
• High-resolution genomic profiles of human lung cancer.

  2005cited by this paper
• lin-35 Rb acts in the major hypodermis to oppose ras-mediated vulval induction in C. elegans.

  2005cited by this paper
• E2F and cell survival: context really is key.

  2005cited by this paper
• Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma

  2005cited by this paper
• High‐resolution analysis of 16q22.1 in breast carcinoma using DNA amplifiable probes (multiplex amplifiable probe hybridization technique) and immunohistochemistry

  2005cited by this paper
• Prognostic Role of E2F1 and Members of the CDKN2A Network in Gastrointestinal Stromal Tumors

  2005cited by this paper
• Mammalian cyclin-dependent kinases.

  2005cited by this paper
• A role for E2F6 in the restriction of male-germ-cell-specific gene expression.

  2005cited by this paper
• Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription

  2005cited by this paper
• Cyclin-dependent kinase 4 expression is essential for neu-induced breast tumorigenesis.

  2005cited by this paper
• Cyclin D1, E2F1 expression levels are associated with characteristics and prognosis of esophageal squamous cell carcinoma.

  2005cited by this paper
• Over-expression of E2F-1 in esophageal squamous cell carcinoma correlates with tumor progression.

  2004cited by this paper
• Living with or without cyclins and cyclin-dependent kinases.

  2004cited by this paper
• Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.

  2004cited by this paper
• A common set of gene regulatory networks links metabolism and growth inhibition.

  2004cited by this paper
• Distinct Chromosomal Bias of Gene Expression Signatures in the Progression of Hepatocellular Carcinoma

  2004cited by this paper
• Diabetes and exocrine pancreatic insufficiency in E2F1/E2F2 double-mutant mice.

  2004cited by this paper
• Role of an Atypical E2F Transcription Factor in the Control of Arabidopsis Cell Growth and Differentiation

  2004cited by this paper
• E2Fs link the control of G1/S and G2/M transcription

  2004cited by this paper
• The E2F family: specific functions and overlapping interests

  2004cited by this paper
• Transcription factor E2F3 overexpressed in prostate cancer independently predicts clinical outcome

  2004cited by this paper
• Overexpression of the replication licensing regulators hCdt1 and hCdc6 characterizes a subset of non-small-cell lung carcinomas: synergistic effect with mutant p53 on tumor growth and chromosomal instability--evidence of E2F-1 transcriptional control over hCdt1.

  2004cited by this paper
• High Incidence of Thymic Epithelial Tumors in E2F2 Transgenic Mice*

  2004cited by this paper
• Overexpression of E2F1 associated with LOH at RB locus and hyperphosphorylation of RB in non-small cell lung carcinoma

  2004cited by this paper
• Gene expression profiling of 1p35–36 genes in neuroblastoma

  2004cited by this paper
• E2F-Dependent Histone Acetylation and Recruitment of the Tip60 Acetyltransferase Complex to Chromatin in Late G1

  2004cited by this paper
• Wagging the dogma; tissue-specific cell cycle control in the mouse embryo.

  2004cited by this paper

• E2F1 K117 methylation by SETD6 disrupts BRD4–E2F1 binding and modulates E2F1 chromatin binding and gene regulation in prostate cancer cells

  2026cites this paper
• E2f1 transcription factor is required for neurodevelopment through regulation of conserved miR-33 and RhoGEF trio

  2026cites this paper
• UBE2M as a bridge spanning neddylation and cell cycle regulation in colorectal adenocarcinoma.

  2026cites this paper
• Targeting the master of the replication fork-PCNA.

  2026cites this paper
• Systems level phosphoproteomics reveals CAMKK2 driven kinase signaling underlying malignant phenotypes in gastric cancer

  2026cites this paper
• Adenosine-Specific Transcriptional Programs in Murine Connective Tissue-Type Mast Cells.

  2026cites this paper
• Glucosamine suppresses hepatocellular carcinoma progression through dual inhibition of cell cycle progression and nucleotide metabolism.

  2026cites this paper
• E2F Transcription Factor 8 Contributes to the Pathogenesis of Alzheimer's Disease Accompanied with Decreased Expression of Matrix Metalloproteinase-9 and B-cell Lymphoma 2.

  2026cites this paper
• DSN1 drives breast cancer progression via cell cycle regulation: diagnostic and therapeutic implications

  2026cites this paper
• Complex-specific inhibitors for interrogating ATAC histone acetyltransferase complex

  2026cites this paper
• Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers.

  2026cites this paper
• Ribosome biogenesis rate, a parameter of sensitivity to chemotherapeutic drugs inhibiting rRNA synthesis

  2026cites this paper
• KLF11 interacts with MDM2 to stabilize E2F1 and promotes DNA damage repair to induce radioresistance in esophageal cancer cells.

  2026cites this paper
• Separate transcription and splicing gene networks are linked and coordinated by the pRb–E2F pathway

  2026cites this paper
• From Transcription Factors Dysregulation to Malignancy: In Silico Reconstruction of Cancer’s Foundational Drivers—The Eternity Triangle

  2025cites this paper
• Targeting TUBG1 in RB1‐negative tumors

  2025cites this paper
• Integrating single-cell transcriptomics and whole-genome CRISPR CAS9 screen identifies a cell cluster associated with tumor dependency in triple-negative breast cancer

  2025cites this paper
• TSPAN7 inhibits pancreatic cancer progression by suppressing DNA double-strand break repair and enhances sensitivity to immunochemotherapy.

  2025cites this paper
• Enhanced Apoptosis in Melanoma Cells via Synergistic Action of Luteolin and 5-FU Through Oxidative Stress Modulation

  2025cites this paper
• A novel near-infrared fluorescent hERG potassium channel probe for glioblastoma therapy and imaging

  2025cites this paper
• Integrating single-cell sequencing and clinical insights to explore malignant transformation in odontogenic keratocyst

  2025cites this paper
• Precision prognostication in neuroblastomas via clinically validated E2F activity signatures

  2025cites this paper
• E2F5 Accelerates Vascular Smooth Muscle Cells Phenotype Switching in Diabetic Atherosclerosis through Activating Wnt/β-Catenin Pathway.

  2025cites this paper
• Structural mechanism for the recognition of E2F1 by the ubiquitin ligase adaptor Cyclin F

  2025cites this paper
• Emerging Role of the DREAM Complex in Cancer and Therapeutic Opportunities

  2025cites this paper
• Single-cell technology reveals the crosstalk between tumor cells and immune cells: driving immune signal transduction and inflammation-mediated cardiac dysfunction in the tumor microenvironment of colorectal cancer

  2025cites this paper
• The Role of WDR77 in Cancer: More Than a PRMT5 Interactor.

  2025cites this paper
• DLGAP5 upregulates E2F1 to promote prostate adenocarcinoma neuroendocrine differentiation.

  2025cites this paper
• A novel role for the E2F transcription factor and the ER stress sensor IRE1 in cytoplasmic DNA accumulation

  2025cites this paper
• B cell extracellular vesicles influence melanoma response to immune checkpoint therapy

  2025cites this paper
• Immune responses to human papillomavirus infection and vaccination

  2025cites this paper
• Biomarkers and potential function analysis of triple-negative breast cancer screening based on bioinformatics

  2025cites this paper
• GATA3 and E2F6 negatively regulate WDR77 expression to inhibit prostate cancer cell growth

  2025cites this paper
• BUB1, miR-495-3p, and E2F1/E2F8 axis is associated with poor prognosis of breast cancer patients and infiltration of Th2 cells in the tumor microenvironment

  2025cites this paper
• Bimodality in pan-cancer proteomics reveals new opportunities for biomarker discovery

  2025cites this paper
• Dissection of tumoral niches using spatial transcriptomics and deep learning

  2025cites this paper
• Accurate prediction of multiple RNA modifications from nanopore direct RNA sequencing data with RNANO

  2025cites this paper
• TP53 missense–specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer

  2025cites this paper
• Nukleosidoen bidezko tratamenduak ondesteko minbizi zelulen egonkortasun genomikoa berreskuratzen du baina ez du migratzeko gaitasuna ekiditen

  2025cites this paper
• Identification of the role of MED6 in the development and prognosis of lung adenocarcinoma based on multi-omics profiling

  2025cites this paper
• Case Report and Literature Review: Overexpression of HMGA in Concomitant Plurihormonal Tumor and Papillary Thyroid Carcinoma

  2025cites this paper
• Exploring the Genetic Orchestra of Cancer: The Interplay Between Oncogenes and Tumor-Suppressor Genes

  2025cites this paper
• Using Cancer Profiles to Identify Synthetic Lethal Therapeutic Targets and Predictive Biomarkers in Cancer Gene Dependency Data

  2025cites this paper
• The role of miR-150-5p/E2F3/survivin axis in the pathogenesis of plasmablastic lymphoma and its therapeutic potential

  2025cites this paper
• Integrated pan-cancer analysis revealed therapeutic targets in the ABC transporter protein family

  2025cites this paper
• RSK1-driven TRIM28/E2F1 feedback loop promotes castration-resistant prostate cancer progression

  2025cites this paper
• Molecular drivers in primary brain tumor formation.

  2025cites this paper
• E2F transcription factors as multimodal biomarkers for pan-cancer management

  2025cites this paper
• Determinant of Aggressive Phenotype in Metastatic Hormone-Sensitive Prostate Cancer Depends on an Intrinsic, Highly Aggressive Cell Cluster: Integrated Single-Cell RNA and Whole Transcriptomic Sequencing Analyses

  2025cites this paper
• Insights into the E2F target genes in breast cancer: associations of pathway genes with prognosis and immune cell filtration based on in silico and ex vivo analyses

  2025cites this paper
• Do Glioma Cells Rewire Neural Circuits through Epigenetic Changes? DNA Methylation Analysis of Genes Involved in Neuron–Glioma Communication in the Human Frontal Cortex

  2025cites this paper
• Repurposing Mercaptopurine Through Collateral Lethality to Treat Cancers with Somatic RB1–NUDT15 Loss

  2025cites this paper
• The role of tribbles homolog 2 in cell proliferation

  2025cites this paper
• Acquisition of discrete immune suppressive barriers contributes to the initiation and progression of preinvasive to invasive human lung cancer

  2025cites this paper
• E2F7 promotes ESCC progression and cisplatin resistance through transcriptional activation of DVL3 and the Wnt signaling pathway

  2025cites this paper
• Sexually transmitted human papillomavirus and related sequelae

  2025cites this paper
• A niche-dependent redox rheostat regulates epithelial stem cell fate

  2025cites this paper
• SPC25 upregulates CCND1 to promote the progression of esophageal squamous cell carcinoma by inhibiting MDM2-mediated E2F1 ubiquitination

  2025cites this paper
• Retinocytoma: understanding pathogenesis, diagnosis, and treatment approaches

  2025cites this paper
• Significance of LRFN4 in prognosis and tumor microenvironment of lung adenocarcinoma

  2025cites this paper
• E2F1-induced PTPRG-AS1 inhibits radiosensitivity by targeting the miR-670-3p/SYPL1 axis in colorectal cancer

  2025cites this paper
• Dissecting the impact of transcription factor dose on cell reprogramming heterogeneity using scTF-seq

  2025cites this paper
• CANTAC-seq analysis reveals E2f1 and Otx1 coordinate zygotic genome activation in Xenopus tropicalis

  2025cites this paper
• Elimination of docetaxel-induced senescence attenuates malignant progression in RB1-deficient CRPC

  2025cites this paper
• Inhibiting cholesterol synthesis halts rhabdomyosarcoma growth via ER stress and cell cycle arrest

  2025cites this paper
• Multidimensional pan-cancer analysis reveals the impact of PPIA on tumor epigenetic modifications and immune regulation

  2025cites this paper
• Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment

  2025cites this paper
• Age-associated G-quadruplex accumulation and DDX5 loss shape chromatin landscapes in human astrocytes

  2025cites this paper
• Dedifferentiation-Driven Oncogenic Stemness Promotes Tumor-Sustaining Adaptability in the Intestinal Epithelium

  2025cites this paper
• NIMA-related kinase 2: A master regulator of mitotic fidelity and chromosomal instability in cancer: From mechanisms to therapeutic targeting.

  2025cites this paper
• The Nutrigenomic Effect of Mela Rosa Marchigiana Callus Extract on Cellular Senescence: Insight From a Preliminary In Vitro Study

  2025cites this paper
• Structural mechanism for recognition of E2F1 by the ubiquitin ligase adaptor Cyclin F

  2025cites this paper
• E2F8-induced GRPEL2 promoted colorectal cancer progression via targeting TIGAR

  2025cites this paper
• FBXO5-mediated RNF183 degradation prevents endoplasmic reticulum stress-induced apoptosis and promotes colon cancer progression

  2024cites this paper
• The role of cell cycle-related genes in the tumorigenesis of adrenal and thyroid neuroendocrine tumors

  2024cites this paper
• Mitochondrial uncouplers inhibit oncogenic E2F1 activity and prostate cancer growth

  2024cites this paper
• DEAD/H Box 5 (DDX5) Augments E2F1-Induced Cell Death Independent of the Tumor Suppressor p53

  2024cites this paper
• BmE2F1 regulates endoreplication of silk gland cells in silkworm, Bombyx mori.

  2024cites this paper
• E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer

  2024cites this paper
• Cell cycle dysregulation in cancer.

  2024cites this paper
• Anti‑proliferative effects of Drynaria fortunei in a model for triple negative breast cancer

  2024cites this paper
• miR-17-5p Accelerates the Proliferation and Invasion of Colorectal Cancer via Regulating E2F1

  2024cites this paper
• Protein arginine methyltransferases as regulators of cellular stress.

  2024cites this paper
• The N-Terminal Region of the Transcription Factor E2F1 Contains a Novel Transactivation Domain and Recruits General Transcription Factor GTF2H2

  2024cites this paper
• Double-Faced Immunological Effects of CDK4/6 Inhibitors on Cancer Treatment: Challenges and Perspectives

  2024cites this paper
• Evaluating the impact of Xanthoparmelia conspersa extracts on signaling in HeLa cells and exploring their diverse biological activities

  2024cites this paper
• Flubendiamide provokes oxidative stress, inflammation, miRNAs alteration, and cell cycle deregulation in human prostate epithelial cells: The attenuation impact of synthesized nano-selenium using Trichoderma aureoviride.

  2024cites this paper
• Homoharringtonine promotes non-small-cell lung cancer cell death via modulating HIF-1α/ERβ/E2F1 feedforward loop.

  2024cites this paper
• RRM2 inhibition alters cell cycle through ATM/Rb/E2F1 pathway in atypical teratoid rhabdoid tumor

  2024cites this paper
• Towards the genomic sequence code of DNA fragility for machine learning

  2024cites this paper
• Development of natural product-based targeted protein degraders as anticancer agents.

  2024cites this paper
• E2F1 Promotes the Occurrence of Head and Neck Squamous Cell Carcinoma and Serves as a Prognostic Biomarker

  2024cites this paper
• Pan-cancer analysis identifies the oncogenic role of CCNE1 in human cancers

  2024cites this paper
• BOD1L mediates chromatin binding and non-canonical function of H3K4 methyltransferase SETD1A

  2024cites this paper
• The E2F family: a ray of dawn in cardiomyopathy

  2024cites this paper
• Nucleocytoplasmic β‐catenin expression contributes to neuroendocrine differentiation in muscle invasive bladder cancer

  2024cites this paper
• Neuregulin1 Nuclear Signaling Influences Adult Neurogenesis and Regulates a Schizophrenia Susceptibility Gene Network within the Mouse Dentate Gyrus

  2024cites this paper
• Unveiling the role of UPF3B in hepatocellular carcinoma: Potential therapeutic target

  2024cites this paper
• E2F1 Facilitates the Proliferation and Stemness of Gastric Cancer Cells by Activating CDC25B Transcription and Modulating the MAPK Pathway

  2024cites this paper
• Posttranslational modifications of E2F family members in the physiological state and in cancer: Roles, mechanisms and therapeutic targets.

  2024cites this paper